Phenolic compounds have become interesting bioactive antioxidant compounds with implications for obesity, cancer and inflammatory gastrointestinal pathologies. As the influence of digestion and gut microbiota on antioxidant behavior is yet to be completely elucidated, and due to limitations associated to in vivo studies, dynamic in vitro gastrointestinal models have been promoted. A systematic review was conducted of different databases (PubMed, Web of Science and Scopus) following PRISMA guidelines to assess different dynamic digestion models and assay protocols used for phenolic compound research regarding bioaccesibility and interaction with colonic microbiota. Of 284 records identified, those including dynamic multicompartmental digestion models for the study of phenolic compound bioaccesibility, bioactivity and the effects of microbiota were included, with 57 studies meeting the inclusion criteria. Different conditions and experimental configurations as well as administered doses, sample treatments and microbiological assays of dynamic digestion studies on polyphenols were recorded and compared to establish their relevance for the dynamic in vitro digestion of phenolic compounds. While similarities were observed in certain experimental areas, a high variability was found in others, such as administered doses. A description of considerations on the study of the digestion of phenolic compounds is proposed to enhance comparability in research.
Among vegetable oils, chia oil has been gaining interest in recent years due to its high linolenic acid content (ALA, 18:3 ω3). The aim of this work was to study the influence of the particle size of encapsulated purified chia oil (PCO) on the encapsulation efficiency and PCO release during in vitro digestion. PCO micro- and nano-sized particles with sodium alginate (SA) as an encapsulating agent (ME-PCO-SA and NE-PCO-SA) were designed by micro and nano spray-drying, respectively, applying a central composite plus star point experimental design. NE-PCO-SA showed a smaller particle size and higher encapsulation efficiency of PCO than ME-PCO-SA (0.16 μm vs. 3.5 μm; 98.1% vs. 92.0%). Emulsions (NE-PCO and ME-PCO) and particles (NE-PCO-SA and ME-PCO-SA) were subjected to in vitro static gastrointestinal digestion. ME-PCO and NE-PCO showed sustained oil release throughout the three phases of digestion (oral, gastric and intestinal phases), whereas the PCO release from ME-PCO-SA and NE-PCO-SA occurred mainly in the intestinal phase, showing the suitability of sodium alginate as an intestine-site release polymer. Nano-sized particles showed a significantly higher PCO release after in vitro digestion (NE-PCO-SA, 78.4%) than micro-sized particles (ME-PCO-SA, 69.8%), and also higher bioaccessibility of individual free fatty acids, such as C18:3 ω-3 (NE-PCO-SA, 23.6%; ME-PCO-SA, 7.9%), due to their greater surface area. However, when ME-PCO-SA and NE-PCO-SA were incorporated into yogurt, the PCO release from both particle systems after the digestion of the matrix was similar (NE-PCO-SA, 58.8%; ME-PCO-SA-Y, 61.8%), possibly because the calcium ions contained in the yogurt induced partial ionic gelation of SA, impairing the PCO release. Sodium alginate spray-dried micro and nanoparticles showed great potential for vehiculation of omega-3 rich oils in the design of functional foods.
The development of phenolic-based functional food ingredients is of growing interest due to their beneficial effects on human health. This study investigated the combined influence of microparticle physical state, phenolic compound type (gallic acid, GA; and ellagic acid, EA), and model food matrix on the release profile, bioaccessibility, and antioxidant activity of GA and EA during in vitro gastrointestinal digestion. GA and EA were encapsulated with inulin (In) by spray-drying. By varying formulation and operational conditions, both semicrystalline (GA-InSc, EA-InSc) and amorphous (GA-InA, EA-InA) microparticles were obtained. Microparticles were characterized for crystallinity, encapsulation efficiency, particle size, morphology, and release profile during in vitro simulated gastrointestinal digestion following the INFOGEST method. The physical state of microparticles and type of phenolic compound critically influenced release profile, bioaccessibility, and antioxidant activity during digestion. GA, being more water-soluble, was rapidly released, reaching nearly 100% in the gastric phase, whereas EA exhibited limited gastric release and higher intestinal release, particularly in EA-InSc. Incorporation into different food matrices further modulated these effects; carbohydrate- and blend-based matrices improved phenolic release and antioxidant activity for both compounds. These findings highlight the importance of microparticle formulation, phenolic characteristics, and matrix interactions in designing functional food ingredients with optimized health benefits.
This study compared the physicochemical properties of inulin caffeate, where caffeic acid (CA) was covalently bound to inulin (CA-Inu, degree of substitution: 0.07), with CA spray-dried inulin microparticles (Mp(CA/Inu)), as well as release profiles of CA from CA-Inu and Mp(CA/Inu) under in vitro simulated gastrointestinal digestion. Encapsulation by spray drying was optimized using a Central Composite Design, achieving an encapsulation efficiency of 98%. CA was rapidly released from Mp(CA/Inu) during the oral and gastric phases, followed by a slight decrease in the intestinal phase due to interaction with digestive enzymes. In contrast, no release of CA was detected from CA-Inu during the oral and gastric phases. Approximately 30% was released in the intestinal phase, with a further increase in the colonic phase, especially in the presence of inulinase. This strategy, based on the covalent binding of phenolic compounds to biopolymers, can promote targeted delivery in the later stages of gastrointestinal digestion.